Orthofix Medical (OFIX) Long-Term Deferred Tax (2010 - 2022)

Orthofix Medical has disclosed Long-Term Deferred Tax across 13 years of filings, most recently posting $1.5 million for Q3 2022.

• Quarterly Long-Term Deferred Tax fell 93.21% year-over-year to $1.5 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.5 million (down 93.21% YoY) and the FY2021 annual result came in at $1.8 million, down 92.93% from the prior year.
• Long-Term Deferred Tax climbed to $1.5 million in Q3 2022, from $1.5 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $39.6 million in Q3 2019 and troughed at $1.5 million in Q2 2022.
• A 5-year average of $25.8 million and a median of $30.6 million in 2018 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2018 — Long-Term Deferred Tax soared 42.52% — and 2022, when it plunged 93.21%.
• Tracing OFIX's Long-Term Deferred Tax over 5 years: stood at $33.2 million in 2018, then increased by 5.68% to $35.1 million in 2019, then retreated by 28.69% to $25.0 million in 2020, then sank by 92.93% to $1.8 million in 2021, then declined by 12.82% to $1.5 million in 2022.
• Business Quant data shows OFIX's Long-Term Deferred Tax at $1.5 million in Q3 2022, $1.5 million in Q2 2022, and $1.9 million in Q1 2022.